Watch out for Ericka Iny, McGill Medicine and Health Sciences rising star and future surgeon, who presented her poster on the impact of margin width on #breastcanceroutcomes post #NAC at #ESSO42 ! European Society of Surgical Oncology (ESSO) Lady Davis Institute McGill Division of General Surgery

Predictors of nodal mets in early stage HER2+ breast cancer: Deciding on approach with NAC vs. upfront surgery

Sohayb Faleh Ipshita Prakash McGill Surgery McGill General Surgery Stephanie Wong MD MPH

European Society of Surgical Oncology (ESSO) IR Yazan MASANNAT 🇯🇴🇬🇧 Andreas Karakatsanis (he/him) SoMe4Breast

bit.ly/44bMsFV

A fantastic podium presentation by my future #surgicaloncology colleague Élise Di Lena on our important work showing the #safety of surgical de-escalation in women with #multipleipsilateralbreastcancer post #NAC ! She killed it at #ESSO42 ! McGill Division of General Surgery European Society of Surgical Oncology (ESSO)

We are so lucky to have such amazing trainees! Well done on a fantastic showing. You did us proud! McGill General Surgery Society of Surgical Oncology McGill Breast Outcomes Research Group #mBORG

Happening now at #SSO2023 ! Excellent talk by Dr. Selwyn Vickers on addressing disparities in clinical trials! Zip code more important than genetic code...

Welcome to our new McGill General Surgery cohort! Excited for you to join the family!

A call to action - we are discussing huge disparities in care provision and outcomes at #ISW2022Vienna ⁦Breast Surgery International⁩ - perhaps modern technology & approaches might facilitate better pathways in under resourced countries

Thank you Chantal Reyna and WomenSurgeons for the fantastic session and lineup of speakers! 👏🏽👏🏽👏🏽 #BSI2022 #ISW2022

What a view 😉 Mathieu Rousseau summarizing the landscape of neoadjuvant therapies for #esophagealcancer . #ISW2022

Getting things started at #BSI2022 #ISW2022 in beautiful #Vienna ! Fantastic first scientific session!
📸: Mathieu Rousseau

We’ll done Mathieu Rousseau 👏🏽👏🏽👏🏽 So proud!

Thank you for helping us navigate this evolving landscape for high risk HR+/HER2- #breastcancer !

Survey study of the ASBrS members: Margin management and adjuvant therapy for phyllodes tumors. 53% of the members wouldn’t re-excise a positive margin for a benign phyllodes tumor. #ASBrS2022 #ASBrS22

Welcome to the future of #globalhealth 💪🏽

Hot off the press! Our study describing contemporary trends of NACT use in early stage #breastcancer shows opportunities to ⬆️ #valuebasedhealthcare
#bcsm , Rachel Adams Greenup
ResearchGate: researchgate.net/publication/35…

This was one of my favourite things from fellowship! Congratulations Jennifer Plichta MD (she/her)!!

Just posted a photo instagram.com/p/CTcQxm8neKif…

Great opportunity to support Sub-Saharan women surgeons through COSECSA! Best wishes Shelley Hwang! Pole pole = summit!

It’s all about those silver linings! Thank you Matteo Lambertini, MD PhD and team for this very important work!